Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
Copyright© 2020 Ferrata Storti Foundation..
Major surgery is associated with an increased risk of venous thromboembolism (VTE), thus the application of mechanical or pharmacologic prophylaxis is recommended. The incidence of VTE in patients with inherited platelet disorders (IPD) undergoing surgical procedures is unknown and no information on the current use and safety of thromboprophylaxis, particularly of low-molecular-weight-heparin in these patients is available. Here we explored the approach to thromboprophylaxis and thrombotic outcomes in IPD patients undergoing surgery at VTE-risk participating in the multicenter SPATA study. We evaluated 210 surgical procedures carried out in 155 patients with well-defined forms of IPD (VTE-risk: 31% high, 28.6% intermediate, 25.2% low, 15.2% very low). The use of thromboprophylaxis was low (23.3% of procedures), with higher prevalence in orthopedic and gynecological surgeries, and was related to VTE-risk. The most frequently employed thromboprophylaxis was mechanical and appeared to be effective, as no patients developed thrombosis, including patients belonging to the highest VTE-risk classes. Low-molecular-weight-heparin use was low (10.5%) and it did not influence the incidence of post-surgical bleeding or of antihemorrhagic prohemostatic interventions use. Two thromboembolic events were registered, both occurring after high VTE-risk procedures in patients who did not receive thromboprophylaxis (4.7%). Our findings suggest that VTE incidence is low in patients with IPD undergoing surgery at VTE-risk and that it is predicted by the Caprini score. Mechanical thromboprophylaxis may be of benefit in patients with IPD undergoing invasive procedures at VTE-risk and low-molecular-weight-heparin should be considered for major surgery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:105 |
|---|---|
| Enthalten in: |
Haematologica - 105(2020), 7 vom: 26. Juli, Seite 1948-1956 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Paciullo, Francesco [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticoagulants |
|---|
| Anmerkungen: |
Date Completed 27.04.2021 Date Revised 03.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3324/haematol.2019.227876 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301663823 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301663823 | ||
| 003 | DE-627 | ||
| 005 | 20231225105110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2019.227876 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1005.xml |
| 035 | |a (DE-627)NLM301663823 | ||
| 035 | |a (NLM)31558677 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Paciullo, Francesco |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2021 | ||
| 500 | |a Date Revised 03.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© 2020 Ferrata Storti Foundation. | ||
| 520 | |a Major surgery is associated with an increased risk of venous thromboembolism (VTE), thus the application of mechanical or pharmacologic prophylaxis is recommended. The incidence of VTE in patients with inherited platelet disorders (IPD) undergoing surgical procedures is unknown and no information on the current use and safety of thromboprophylaxis, particularly of low-molecular-weight-heparin in these patients is available. Here we explored the approach to thromboprophylaxis and thrombotic outcomes in IPD patients undergoing surgery at VTE-risk participating in the multicenter SPATA study. We evaluated 210 surgical procedures carried out in 155 patients with well-defined forms of IPD (VTE-risk: 31% high, 28.6% intermediate, 25.2% low, 15.2% very low). The use of thromboprophylaxis was low (23.3% of procedures), with higher prevalence in orthopedic and gynecological surgeries, and was related to VTE-risk. The most frequently employed thromboprophylaxis was mechanical and appeared to be effective, as no patients developed thrombosis, including patients belonging to the highest VTE-risk classes. Low-molecular-weight-heparin use was low (10.5%) and it did not influence the incidence of post-surgical bleeding or of antihemorrhagic prohemostatic interventions use. Two thromboembolic events were registered, both occurring after high VTE-risk procedures in patients who did not receive thromboprophylaxis (4.7%). Our findings suggest that VTE incidence is low in patients with IPD undergoing surgery at VTE-risk and that it is predicted by the Caprini score. Mechanical thromboprophylaxis may be of benefit in patients with IPD undergoing invasive procedures at VTE-risk and low-molecular-weight-heparin should be considered for major surgery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 650 | 7 | |a Heparin, Low-Molecular-Weight |2 NLM | |
| 700 | 1 | |a Bury, Loredana |e verfasserin |4 aut | |
| 700 | 1 | |a Noris, Patrizia |e verfasserin |4 aut | |
| 700 | 1 | |a Falcinelli, Emanuela |e verfasserin |4 aut | |
| 700 | 1 | |a Melazzini, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Orsini, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Zaninetti, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Abdul-Kadir, Rezan |e verfasserin |4 aut | |
| 700 | 1 | |a Obeng-Tuudah, Deborah |e verfasserin |4 aut | |
| 700 | 1 | |a Heller, Paula G |e verfasserin |4 aut | |
| 700 | 1 | |a Glembotsky, Ana C |e verfasserin |4 aut | |
| 700 | 1 | |a Fabris, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera, Jose |e verfasserin |4 aut | |
| 700 | 1 | |a Lozano, Maria Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Butta, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Favier, Remi |e verfasserin |4 aut | |
| 700 | 1 | |a Cid, Ana Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Fouassier, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Podda, Gian Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Santoro, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Grandone, Elvira |e verfasserin |4 aut | |
| 700 | 1 | |a Henskens, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a Nurden, Paquita |e verfasserin |4 aut | |
| 700 | 1 | |a Zieger, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Cuker, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Devreese, Katrien |e verfasserin |4 aut | |
| 700 | 1 | |a Tosetto, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a De Candia, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a Dupuis, Arnaud |e verfasserin |4 aut | |
| 700 | 1 | |a Miyazaki, Koji |e verfasserin |4 aut | |
| 700 | 1 | |a Othman, Maha |e verfasserin |4 aut | |
| 700 | 1 | |a Gresele, Paolo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d 1947 |g 105(2020), 7 vom: 26. Juli, Seite 1948-1956 |w (DE-627)NLM000081892 |x 1592-8721 |7 nnns |
| 773 | 1 | 8 | |g volume:105 |g year:2020 |g number:7 |g day:26 |g month:07 |g pages:1948-1956 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3324/haematol.2019.227876 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 105 |j 2020 |e 7 |b 26 |c 07 |h 1948-1956 | ||